Muscular Dystrophy

At Nemours, we promise to do whatever it takes to treat children as we would our own. When your child comes to Nemours, we know you’re placing your trust in us. This trust and our dedication to improving the health of your child is what inspires us to provide exceptional care and the most satisfying experience possible.


See What We're Doing in Muscular Dystrophy Research

Nemours takes great pride in research — so that we can better serve children today and in the future with the most advanced treatments available. One example is Nemours’ Pediatric Engineering Research Lab (PERL), part of the Center for Orthopedics Research and Development (CORD). Here, our researchers are responsible for developing amazing new technologies, devices, and therapies that can dramatically change the lives of kids with muscular dystrophy (MD) and other disorders. Watch a video about one of these devices, called the Wilmington Robotic EXoskeleton (WREX).

And we often offer clinical trials related to muscular dystrophy. A clinical trial is a study that evaluates new medicines, new devices, new treatments, or new applications for old treatments. Clinical trials are safe and supervised by a qualified physician, under strict guidance of the Food and Drug Administration (FDA). Patient safety is extremely important to the FDA, to those conducting the studies, and to everyone at Nemours. In a clinical trial, children participating in the study are monitored closely — and families may refuse any aspect of the study treatment or completely discontinue their child’s participation in the clinical trial at any time.

For information about current clinical trials in:
  • Wilmington, DE, call: (302) 651-6800
  • Jacksonville, FL, call: (904) 697-3529

Is a Clinical Trial Right for Your Child? »